SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hochman David P

(Last)

(First)

(Middle)

C/O CORBUS PHARMACEUTICALS HOLDINGS, INC

500 RIVER RIDGE DRIVE

(Street)

NORWOOD

02062

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Corbus Pharmaceuticals Holdings, Inc. [ CRBP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
05/24/2018

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								459,500	D
Common Stock								4,300	I	By Solomon Asher Hochman Trust of 2005
Common Stock								4,300	I	By Hannah Hochman Trust of 2007
Common Stock								4,300	I	By Judah Herman Hochman Trust of 2009
Common Stock	05/24/2018		G⁽¹⁾	V	220,000	D	$0.00	0⁽²⁾	I	By NSH 2008 Family Trust
Common Stock	05/24/2018		G⁽¹⁾	V	110,000	A	$0.00	120,000⁽²⁾	I	By DPH 2008 Trust
Common Stock	05/24/2018		G⁽¹⁾	V	110,000	A	$0.00	110,000⁽²⁾	I	By SHA 2008 Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option(right to buy)⁽³⁾	$5.93	05/24/2018		A	V	34,000		⁽³⁾	05/24/2028	Common Stock	34,000	$0.00	34,000	D

Explanation of Responses:

1. The reporting person is a co-trustee of each of the NSH 2008 Family Trust, of which the reporting person is a beneficiary, the DPH 2008 Trust, of which the reporting person is a beneficiary, and the SHA 2008 Trust, of which the reporting person's sister is a beneficiary. On May 24, 2018, the co-trustees of the NSH 2008 Family Trust caused all of the shares of Common Stock of Corbus Pharmaceuticals Holdings, Inc. (the "Company") then held in the name of such trust to be transferred in equal portions to the DPH 2008 Trust and the SHA 2008 Trust, in accordance with the Trust Agreement Establishing NSH 2008 Family Trust, dated May 1, 2008.

2. On March 15, 2018, the reporting person filed a Form 4 which inadvertently reported that a purchase of 5,000 shares of Common Stock was made for the account of the NSH 2008 Family Trust. In fact, such purchase was made for the account of the DPH 2008 Trust. Accordingly, Column 5 of Table I of this Form 4 reflects that, as of immediately prior to the transactions reported hereby, 220,000 shares were held in the name of the NSH 2008 Family Trust and 10,000 shares were held in the name of the DPH 2008 Trust.

3. The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.

Remarks:

	/s/ David Hochman	05/29/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.